There is probably no other sector that imposes such high demands on the handling of goods as the pharmaceutical sector. Drugs and other medical products are particularly sensitive; even the smallest temperature fluctuation can impair their effectiveness and shelf life. The highest levels of quality, hygiene and safety are therefore crucial when handling pharmaceutical products – and logistics service providers who want to operate in the pharmaceutical sector have to prove that they meet the required EU standards as part of their GDP (Good Distribution Practices) certification.
Militzer & Münch Germany committed to achieving GDP certification in 2021 – with success: Last year, the country organization attained the certificate, with Charlotte Dürr, Group Project Manager Pharmaceuticals at Militzer & Münch, the leading force.
What does the GDP certification mean for Militzer & Münch Germany?
The certification process is very demanding and extensive. The hardest part was to create a basic framework of documentation and standards that covers all areas of the EU GDP directive. In addition, carriers need to be thoroughly checked and assessed for their quality and compliance.
With the quality system in place, the company can ensure responsible and competent handling of sensitive goods – from Munich to Nairobi or from Berlin to Ulaanbaatar. This helps to continuously certify further group locations. In Poland, the certification audit was successfully passed in March; in Georgia, the first audit is currently being planned.
New opportunities from certification
Worldwide, the healthcare market is booming, and Germany is one of the market leaders. As a GDP-certified logistics service provider, Militzer & Münch can now participate in this sector to a wholly different extent, open up new markets, and address a larger clientele.
The first sales initiatives launched after successful certification showed quick results: many requests for quotations were received for full truck loads by road, including numerous shipments to Central Asia and as far as Mongolia, and by sea and air to various destinations in Africa, the Middle East, and Southeast Asia.
Current pharmaceutical projects
At present, Militzer & Münch Germany is handling transports of pharmaceuticals and medical equipment to Africa, Asia, and Europe, as well as shipments within Europe. There are also imports of raw materials, accessories and medical cannabis.
Future plans
The goal is to further expand the pharmaceutical logistics network to offer customers worldwide the best possible service and products. Where this is not feasible via the Militzer & Münch network directly, the company cooperates with local partners who meet GDP standards. Great potential is seen in pharmaceutical shipments to Central Asia, Southeastern Europe, and Africa.